7 EXPLANATORY NOTES The designations employed and the presentation of the The following abbreviations have been used in the material in the World Drug Report do not imply the present booklet: expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal ATS amphetamine-type stimulants status of any country, territory, city or area, or of its CBD aut. [...] richer, while the long-term implica- The drastic decrease in Afghanistan was the result of a tions may soon be felt in countries of drug ban announced by the Taliban in April 2022, which transit and destination for Afghan was too late to affect the 2022 harvest, but had a major opiates impact on the decisions of farmers in the autumn of 2022 when winter crops were sowed in prevision of the 2023 ha. [...] Route arrows represent the direction of trafficking: origins of the arrows indicate either the area of departure or the one of last provenance, end points of arrows indicate either the area of consumption or the one of next destination of trafficking. [...] Route arrows represent the direction of tracking: origins of the arrows indicate either the area of departure or the one of last provenance, end points of arrows indicate either the area of consumption or the one of next destination of tracking. [...] Number of countries KEY FINDINGS AND CONCLUSIONS DRUG USE HARMS AND IMPACTS Key message Opioids continue to be the most harmful drug class in terms of drug-related deaths, but in half of the reporting countries, cannabis is the drug that most often leads to drug use disorders Findings Many of the 292 million people who have used a drug in People with drug use disorders also suffer from other the p.
- Pages
- 82
- Published in
- Austria
Table of Contents
- WORLD DRUG REPORT 2024 3
- PREFACE 5
- EXPLANATORY NOTES 7
- CONTENTS 9
- KEY FINDINGS AND CONCLUSIONS 11
- WHAT TO WATCH 11
- KEY FINDINGS AND CONCLUSIONS 12
- WHAT TO WATCH 12
- KEY FINDINGS AND CONCLUSIONS 12
- WHAT TO WATCH 12
- KEY FINDINGS AND CONCLUSIONS 14
- WHAT TO WATCH 14
- KEY FINDINGS AND CONCLUSIONS 16
- WHAT TO WATCH 16
- KEY FINDINGS AND CONCLUSIONS 18
- WHAT TO WATCH 18
- KEY FINDINGS AND CONCLUSIONS 20
- WHAT TO WATCH 20
- KEY FINDINGS AND CONCLUSIONS 22
- WHAT TO WATCH 22
- KEY FINDINGS AND CONCLUSIONS 24
- WHAT TO WATCH 24
- KEY FINDINGS AND CONCLUSIONS 26
- WHAT TO WATCH 26
- KEY FINDINGS AND CONCLUSIONS 28
- WHAT TO WATCH 28
- KEY FINDINGS AND CONCLUSIONS 30
- WHAT TO WATCH 30
- KEY FINDINGS AND CONCLUSIONS 32
- WHAT TO WATCH 32
- KEY FINDINGS AND CONCLUSIONS 34
- WHAT TO WATCH 34
- KEY FINDINGS AND CONCLUSIONS 36
- WHAT TO WATCH 36
- KEY FINDINGS AND CONCLUSIONS 38
- WHAT TO WATCH 38
- KEY FINDINGS AND CONCLUSIONS 40
- WHAT TO WATCH 40
- KEY FINDINGS AND CONCLUSIONS 43
- DRUG USE HARMS AND IMPACTS 43
- KEY FINDINGS AND CONCLUSIONS 44
- DRUG USE HARMS AND IMPACTS 44
- KEY FINDINGS AND CONCLUSIONS 46
- DRUG USE HARMS AND IMPACTS 46
- KEY FINDINGS AND CONCLUSIONS 48
- DRUG USE HARMS AND IMPACTS 48
- KEY FINDINGS AND CONCLUSIONS 50
- DRUG USE HARMS AND IMPACTS 50
- KEY FINDINGS AND CONCLUSIONS 52
- DRUG USE HARMS AND IMPACTS 52
- KEY FINDINGS AND CONCLUSIONS 54
- DRUG USE HARMS AND IMPACTS 54
- KEY FINDINGS AND CONCLUSIONS 56
- DRUG USE HARMS AND IMPACTS 56
- KEY FINDINGS AND CONCLUSIONS 58
- DRUG USE HARMS AND IMPACTS 58
- KEY FINDINGS AND CONCLUSIONS 60
- DRUG USE HARMS AND IMPACTS 60
- KEY FINDINGS AND CONCLUSIONS 62
- DRUG USE HARMS AND IMPACTS 62
- KEY FINDINGS AND CONCLUSIONS 64
- DRUG USE HARMS AND IMPACTS 64
- KEY FINDINGS AND CONCLUSIONS 67
- DRUG POLICY LANDSCAPES AND RESPONSES 67
- KEY FINDINGS AND CONCLUSIONS 68
- DRUG POLICY LANDSCAPES AND RESPONSES 68
- KEY FINDINGS AND CONCLUSIONS 70
- DRUG POLICY LANDSCAPES AND RESPONSES 70
- KEY FINDINGS AND CONCLUSIONS 72
- DRUG POLICY LANDSCAPES AND RESPONSES 72
- KEY FINDINGS AND CONCLUSIONS 74
- DRUG POLICY LANDSCAPES AND RESPONSES 74
- KEY FINDINGS AND CONCLUSIONS 76
- DRUG POLICY LANDSCAPES AND RESPONSES 76
- GLOSSARY 79
- GLOSSARY 81
- REGIONAL GROUPINGS 81
